The blood–brain barrier (BBB) is an efficient barrier for molecules and drugs. Multicellular 3D spheroids display reproducible BBB features and functions. The spheroids used here were composed of six brain cell types: Astrocytes, pericytes, endothelial cells, microglia cells, oligodendrocytes, and neurons. They form an in vitro BBB that regulates the transport of compounds into the spheroid. The penetration of fluorescent ultrasmall gold nanoparticles (core diameter 2 nm; hydrodynamic diameter 3–4 nm) across the BBB was studied as a function of time by confocal laser scanning microscopy, with the dissolved fluorescent dye (FAM-alkyne) as a control. The nanoparticles readily entered the interior of the spheroid, whereas the dissolved dye alone did not penetrate the BBB. We present a model that is based on a time-dependent opening of the BBB for nanoparticles, followed by a rapid diffusion into the center of the spheroid. After the spheroids underwent hypoxia (0.1% O2; 24 h), the BBB was more permeable, permitting the uptake of more nanoparticles and also of dissolved dye molecules. Together with our previous observations that such nanoparticles can easily enter cells and even the cell nucleus, these data provide evidence that ultrasmall nanoparticle can cross the blood brain barrier.
Ultrasmall
gold nanoparticles (core diameter 2 nm) were surface-conjugated
with azide groups by attaching the azide-functionalized tripeptide
lysine(N3)-cysteine-asparagine with ∼117 molecules
on each nanoparticle. A covalent surface modification with alkyne-containing
molecules was then possible by copper-catalyzed click chemistry. The
successful clicking to the nanoparticle surface was demonstrated with 13C-labeled propargyl alcohol. All steps of the nanoparticle
surface conjugation were verified by extensive NMR spectroscopy on
dispersed nanoparticles. The particle diameter and the dispersion
state were assessed by high-resolution transmission electron microscopy
(HRTEM), differential centrifugal sedimentation (DCS), and 1H-DOSY NMR spectroscopy. The clicking of fluorescein (FAM-alkyne)
gave strongly fluorescing ultrasmall nanoparticles that were traced
inside eukaryotic cells. The uptake of these nanoparticles after 24
h by HeLa cells was very efficient and showed that the nanoparticles
even penetrated the nuclear membrane to a very high degree (in contrast
to dissolved FAM-alkyne alone that did not enter the cell). About
8 fluorescein molecules were clicked to each nanoparticle.
Ultrasmall gold nanoparticles (diameter about 2nm) were surface-functionalizedw ith cysteine-carrying precision macromolecules. These consistedo fs equence-defined oligo(amidoamine)s (OAAs)w ith either two or six cysteine molecules for binding to the gold surface and either with or withoutaPEG chain (3400 Da). They were characterized by 1 HNMR spectroscopy, 1 HNMR diffusion-ordered spectroscopy (DOSY), small-angle X-ray scattering(SAXS), and high-resolution transmission electron microscopy.T he number of precision macromolecules per nanoparticle was determined after fluorescent labeling by UV spectroscopya nd also by quantitative 1 HNMR spectroscopy.E ach nanoparticle carried between4 0a nd 100 OAA ligands, depending on the number of cysteine units per OAA.T he footprint of each ligandw as about 0.074 nm 2 per cysteinem olecule. OAAs are well suited to stabilize ultrasmall gold nanoparticlesb ys electives urface conjugation and can be used to selectively cover their surface. The presence of the PEG chain considerably increasedt he hydrodynamicd iametero fb oth dissolved macromolecules and macromolecule-conjugated gold nanoparticles.
A strategy toward epitope-selective functionalized nanoparticles
is introduced in the following: ultrasmall gold nanoparticles (diameter
of the metallic core about 2 nm) were functionalized with molecular
tweezers that selectively attach lysine and arginine residues on protein
surfaces. Between 11 and 30 tweezer molecules were covalently attached
to the surface of each nanoparticle by copper-catalyzed azide alkyne
cycloaddition (CuAAC), giving multiavid agents to target proteins.
The nanoparticles were characterized by high-resolution transmission
electron microscopy, differential centrifugal sedimentation, and 1H NMR spectroscopy (diffusion-ordered spectroscopy, DOSY,
and surface composition). The interaction of these nanoparticles with
the model proteins hPin1 (WW domain; hPin1-WW) and Survivin was probed
by NMR titration and by isothermal titration calorimetry (ITC). The
binding to the WW domain of hPin1 occurred with a K
D of 41 ± 2 μM, as shown by ITC. The nanoparticle-conjugated
tweezers targeted cationic amino acids on the surface of hPin1-WW
in the following order: N-terminus (G) ≈ R17 > R14 ≈
R21 > K13 > R36 > K6, as shown by NMR spectroscopy. Nanoparticle recognition
of the larger protein Survivin was even more efficient and occurred
with a K
D of 8 ± 1 μM, as shown
by ITC. We conclude that ultrasmall nanoparticles can act as versatile
carriers for artificial protein ligands and strengthen their interaction
with the complementary patches on the protein surface.
The uptake of fluorescently labeled ultrasmall gold nanoparticles (2 nm) by Gram-negative Escherichia coli bacteria occurs within 1-3 hours. This was demonstrated by confocal laser scanning microscopy (CLSM), structured illumination microscopy (SIM), stochastic optical reconstruction microscopy (STORM), and flow cytometry. For imaging, eGFP-expressing and DsRed2expressing E. coli strains were used in addition to non-fluorescing E. coli strains. Gold nanoparticles were labeled with fluoresceine (FITC), Cy3, and AF647, respectively. Importantly, gold nanoparticles showed no toxicity to the bacteria, indicating a non-lethal nature of the uptake, that is, not related to cell injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.